Repligen
(NASDAQ:RGEN)
$184.75
0[0.00%]
Last update: 4:00PM Get Real Time Here
50%
Overview Rating
Speculative
Technicals Analysis
100
0100
Financials Analysis
20
0100

Repligen Stock (NASDAQ:RGEN), Quotes and News Summary

Repligen Stock (NASDAQ: RGEN) stock price, news, charts, stock research, profile.

Open$184.170
Close-
Volume / Avg.148.578K / 543.887K
Day Range182.560 - 187.250
52 Wk Range110.450 - 211.130
Market Cap$10.304B
P/E Ratio249.595
Dividend Yield-
ExchangeNASDAQ
RSI
40
Short Interest
10.84%
Days to Cover11.64
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Oct 23
4
Nov 23
1
Dec 23
2
Feb
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Repligen Corp.
Sector
Health Care
Industry
Life Sciences Tools & Services
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioproces...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
RGEN
MEDP

FAQ

Q

How do I buy Repligen (RGEN) stock?

A

You can purchase shares of Repligen (NASDAQ: RGEN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Repligen's (RGEN) competitors?

Q

What is the target price for Repligen (RGEN) stock?

A

The latest price target for Repligen (NASDAQ: RGEN) was reported by Stifel on Thursday, February 22, 2024. The analyst firm set a price target for 207.00 expecting RGEN to rise to within 12 months (a possible 12.72% upside). 19 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Repligen (RGEN)?

A

The stock price for Repligen (NASDAQ: RGEN) is $183.6364 last updated Today at March 28, 2024 at 2:15 PM EDT.

Q

Does Repligen (RGEN) pay a dividend?

A

There are no upcoming dividends for Repligen.

Q

When is Repligen (NASDAQ:RGEN) reporting earnings?

A

Repligen’s Q1 earnings are confirmed for Tuesday, April 30, 2024.

Q

Is Repligen (RGEN) going to split?

A

There is no upcoming split for Repligen.

Q

What sector and industry does Repligen (RGEN) operate in?

A

Repligen is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

People Also Watch